Principle Research Solutions, LLC | Spokane, WA logo

Principle Research Solutions, LLC | Spokane, WA

Research site
820 S. McCllen Street, Street 414, Spokane, Washington, United States of America
Contact this site

Gregory Jared

Verified by this site


2 of 6
Status: Active
Trial type: Interventional
Funder type: Industry

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

The purpose of this study is to compare the efficacy and safety of rimegepant versus placebo in the acute treatment of chronic rhinosinusitis (CRS) w...

Active, not recruiting
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Drug: Matching placebo
Drug: rimegepant 75 mg ODT

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 100 mg
Drug: Placebo

Trial conditions

Atopic Dermatitis (2 trials)
Dermatitis (2 trials)
Eczema (2 trials)
Alopecia (1 trial)
Alopecia Areata (1 trial)
COVID-19 (1 trial)
Nasal Polyps (1 trial)
Polyps (1 trial)
Rhinosinusitis (1 trial)
Sinusitis (1 trial)

And 1 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems